Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda's Rozerem To Launch In September Following FDA Approval

Jul 22 2005

• By Andrew Kasper

Related Content

Takeda's Rozerem Will Not Be First-Line Competitor To Ambien, Sanofi Says

Jul 19 2005

Takeda’s Sleep Aid Rozerem Could Avoid Controlled Substance Scheduling, Firm Says

Jul 12 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window